Omne Possibile launched to harness transformative ability of XNA in healthcare, information technology and clever resources

Omne Possibile launched to harness transformative energy of XNA in health care, information and facts

Omne Possibile launched to harness transformative energy of XNA in health care, information and facts engineering and wise supplies

A revolutionary, worldwide technological chief in XNA producing customizable buildings to outperform present DNA and RNA technologies

XNA is at the forefront of the artificial biology revolution, forecast to rework drugs, agriculture, energy, shopper products and IT with a $4 trillion annual financial effect

Started by leading European synthetic biologists

Leuven, Belgium, and Basel, Switzerland 10 May 2021: Omne Possibile (“the Corporation”), a world synthetic biology corporation groundbreaking the XNA revolution, has been released today to harness the ability of XNA (xeno nucleic acids) to completely transform medicine, agriculture, vitality, buyer goods and data engineering. XNA is at the forefront of the synthetic biology revolution, built to get over the constraints of the chemical structures of DNA and RNA systems. It is forecast to have a $4 trillion once-a-year financial impact around the following 10 to 20 a long time, higher than that of the world wide web.1

Patrice Garnier, President and Main Executive Officer of Omne Possibile, explained: “Synthetic biology has been known as the fifth industrial revolution. We feel XNA will be the dominant technological know-how of the 21st century, with a profound affect on all elements of our every day life which includes health care, information and facts technological innovation, vitality, transportation and purchaser products. Omne Possibile unites primary European specialists in the crucial building blocks of synthetic biology and the crucial disciplines of XNA development. Our ambition is to change Europe’s improvements in XNA know-how into a world wide company that will direct the revolution in synthetic genetics.”

“Xenobiology will be to biology what astronautics has been to astronomy.” provides Philippe Marlière, Chairman of the Board of Omne Possibile. “By way of the diversification of the base alphabet and spine motifs of DNA and RNA analogs, our corporation will deliver the sector with a myriad of personalized genetic polymers. Obtaining brought collectively the most ahead-imagining researchers and industrialists in the subject, which include two Nobel laureates, Omne Possibile is set to bring genetic polymers to industry.”

Omne Possibile was co-launched by Patrice Garnier, an entrepreneur with additional than 20 a long time of encounter foremost high-tech corporations, Alexandre Mouradian, a seasoned and visionary trader, and by 3 of Europe’s leading synthetic biologists: Philippe Marlière, Scientific Director at ISSB Evry Piet Herdewijn, Professor of Medicinal Chemistry at KU Leuven Sven Panke, Professor of Bioprocess Engineering at ETH Zürich.

The Enterprise will in the beginning focus on enhancement of XNA polymers for facts storage and XNA building blocks for improved messenger therapeutics:

  • Storage XNA (sXNA) are witnessed as perfect candidates to manage the exponential expansion of details in the coming many years, presenting added benefits in conditions of potential, electrical power use, area necessities and expense.

  • Messenger XNA (mXNA) is created to overcome the constraints of mRNA, the spine of modern vaccine systems in areas like viral infections and most cancers. They also enjoy essential roles in genetic treatment options and in agricultural pest command. mXNA provides the prospective for enormously enhanced chemical functionality and organic steadiness, opening up important new chances in healthcare and other fields.

Omne Possibile combines the key disciplines of XNA enhancement, including chemical synthesis, genetics, directed evolution of enzymes and genomes, automated style of molecules, and bioproduction pathways. It has established an R&D innovation heart in Leuven, Belgium, to emphasis on XNA chemistry, and a second R&D hub in Basel, Switzerland, dedicated to XNA genetics. It intends to mature promptly via a blend of in-home improvement and industrial collaborations.

A scientific advisory board of primary industrialists and globally renowned researchers will be introduced in the upcoming number of weeks to manual the Company’s method.

-Conclude-

About Omne Possibile

Omne Possibile is a revolutionary, worldwide technological leader in XNA, producing customizable constructions to outperform present-day DNA and RNA systems. Its goal is to harness the transformative electric power of XNA in spots which includes healthcare, facts technological innovation and sensible resources. The Company’s preliminary emphasis is on advancement of XNA polymers for information storage and XNA building blocks for improved messenger therapeutics. Omne Possibile has R&D hubs in Leuven, Belgium, and Basel, Switzerland. It was founded by main European synthetic biologists and is supported by a environment class scientific advisory board. For much more details, be sure to take a look at www.omnepossibile.com

Speak to

Omne Possibile
Patrice Garnier, Main Govt Officer
[email protected]

Consilium Strategic Communications
Amber Fennell, Jonathan Birt, Melissa Gardiner, Carina Jurs
+44 () 203 709 5000
[email protected]

1 How the Bio Revolution could remodel the competitive landscape, Michael Chui, Matthias Evers, Alice Zheng, McKinsey Quarterly, Might 2020